Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study.
Jorge Millán-PascualGabriel Valero-LópezFrancisca Iniesta-MartinezMaria Fuensanta Hellin-GilJudith Jimenez-VeigaIsabel Alejandra López-TovarAna Morales-OrtizJosé E Meca-LallanaPublished in: Neurology and therapy (2023)
Treatment with aCD20 or SP1-M therapies appears to be associated with a lower humoral response to vaccines against SARS-CoV-2. Vaccination prior to initiation of these DMTs should be recommended whenever possible.